1-8 of 8
Douglas Burtrum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

Carmine Carpenito, Yiwen Li, George X. Wang, Maria S. Malabunga, Jaafar N. Haidar, Amelie Forest, Mary Y. Murphy, Gerald E. Hall, Cindy Wang, Leyi Shen, Andreas Sonyi, Darin Chin, Anthony L. Pennello, Ivan V. Inigo, David Surguladze, Yung-mae Yao, Douglas Burtrum, Ruslan D. Novosiadly, Kris Persaud, Dale L. Ludwig, Michael D. Kalos
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2730.
https://doi.org/10.1158/1538-7445.AM2018-2730
Published: 01 July 2018
View article titled, Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054
Journal Articles

Abstract 3539: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

Jacqueline Doody, Sneha Mathew, Lan Wu, Yanxia Li, Ying Wang, Kris Persaud, Douglas Burtrum, Paul Balderes, David Surguladze, John Haurum, Dale Ludwig
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3539.
https://doi.org/10.1158/1538-7445.AM2012-3539
Published: 15 April 2012
View article titled, Abstract 3539: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models
Journal Articles

Abrogation of PTEN does not confer resistance to anti-IGF-IR targeted therapy in IGF responsive tumor cells

Douglas Burtrum, Bronek Pytowski, Dale Ludwig
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 425.
Published: 01 May 2007
View article titled, Abrogation of PTEN does not confer resistance to anti-IGF-IR targeted therapy in IGF responsive tumor cells
Journal Articles

A humanized insulin-like growth factor I receptor antibody inhibits multiple myeloma cell growth in vivo through anti-angiogenesis

Kaida Wu, Li Zhou, Kang Zhang, Douglas Burtrum, Dale L. Ludwig, Malcolm A. S. Moore
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1189.
Published: 01 May 2005
View article titled, A humanized insulin-like growth factor I receptor antibody inhibits multiple myeloma cell growth in vivo through anti-angiogenesis
Journal Articles

Synergistic anti-tumor effects of anti-EGFR monoclonal antibody Erbitux® combined with antibodies targeting IGF1R or VEGFR-2

James R. Tonra, Erik Corcoran, Genevieve Makhoul, Douglas Burtrum, Bridget Finnerty, James Huber, Francine E. Carrick, Dale L. Ludwig, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1193.
Published: 01 May 2005
View article titled, Synergistic anti-tumor effects of anti-EGFR monoclonal antibody Erbitux® combined with antibodies targeting IGF1R or VEGFR-2
Journal Articles

Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody

Dan Lu, Haifan Zhang, Dale Ludwig, Anita Persaud, Xenia Jimenez, Douglas Burtrum, Paul Balderes, Meilin Liu, Peter Bohlen, Larry Witte, Zhenping Zhu
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1235.
Published: 01 April 2004
View article titled, Simultaneous blockade of both the epidermal growth factor receptor and the insulin-like growth factor receptor signaling pathways in cancer cells with a fully human recombinant bispecific antibody
Journal Articles

Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.

Dale L. Ludwig, James R. Tonra, Douglas Burtrum, Marie Prewett, Rajiv Bassi, Andrea Hooper, Daniel S. Pereira, Bridget Finnerty, Eric Corcoran, Larry Witte, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 509.
Published: 01 April 2004
View article titled, Potent anti-tumor activity of IGF-I receptor antagonist antibody IMC-A12 alone and in combination with CPT-11.
Journal Articles

A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Daniel S. Pereira, Rajiv Bassi, Rashed Abdullah, Andrea T. Hooper, Henry Koo, Xenia Jimenez, Danielle Johnson, Robin Apblett, Paul Kussie, Peter Bohlen, Larry Witte, Daniel J. Hicklin, Dale L. Ludwig
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8912–8921.
Published: 24 December 2003
View article titled, A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth <em>in Vivo</em>
Open the PDF for A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth <em>in Vivo</em> in another window